Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5672_Библиотеки_им_академика_М_И_Перельмана
.pdf
314
Metals in Medicine, Volume 2
17.
Mater. Today: Proc. 2020, 31, A48–A53.
18.
Environ.
Nanotechnol. Monit. Manag. 2018, 10, 331–338.
19.
Biotechnol. Res. Innov. 2018, 2 (1), 63–73.
20.
Environmental Applications and Implications. Nanomaterials 2016, 6 (11), 209.
21.
Int. J.
Mol. Sci. 2020, 21 (22), 8458.
22.
Int. J. Pharm. 2016, 511 (1), 367–379.
23.
Against Clinically Isolated Pathogens. Colloids Surf. B: Biointerfaces 2011, 85 (2),
360–365.
24.
Leplaea mayombensis. J. Bionanosci. 2018, 12 (3),
422–427.
25.
Application as Electrochemical Current Enhancer. Molecules 2019, 24 (17), 3141.
26. Mangifera indica
Environ. Prog. Sustain. Energy 2018, 37 (1), 283–294.
27.
Garcinia mangostana Fruit Peels. J. Nanomater. 2016, 2016, 1–7.
28.
Gymnocladus assamicus and
its Biological Evaluation. Mater. Lett. 2013, 113, 103–106.
29.
Champia parvula and its Anti-Oxidant and Anticarcinogenic Activity
on Lung Cancer. Particul. Sci. Technol. 2023, 41 (2), 241–249
30.
Applications. J. Saudi Chem. Soc. 2022, 26 (2), 101419.
31.
Process Biochem. 2018, 70, 188–197.
https://t.me/med1917
Principal Applications of Gold Nanoparticles in the Biomedical Field
315
32.
Microorganisms. Nanocon Olomouc, Czech Republic, EU. 2010, 10, 12–18.
33.
Bacillus licheniformis. Bioresour. Technol. 2009, 100 (21),
5356–5358.
34.
Sargassum wightii
Greville. Colloids Surf. B: Biointerfaces. 2007, 57 (1), 97–101.
35.
Fusarium oxysporum.
Chem. Bio. Chem. 2002, 3 (5), 461–463.
36.
Yeast Yarrowia lipolytica NCIM 3589. Colloids Surf. B: Biointerfaces. 2009, 74 (1),
309–316.
37.
Int. J. Nanomed. 2011, 2305–2319.
38.
Silver Nanoparticles by Cylindrocladium floridanum and its Homogeneous Catalytic
Spectrochim. Acta A Mol. Biomol. Spectrosc. 2013, 116,
485–490.
39.
CA: Cancer J. Clin. 2021, 71 (3), 209–249.
40.
J. Nanomater. 2019, 2019, 1–9.
41.
Cancers 2020, 12 (4), 855.
42.
Cancers 2020, 12 (4), 855.
43.
Nanoparticles As a Promising Anti-Cancer-Strategy. Cancers 2021, 13 (11), 2818.
44.
K. Advances in Functional and Structural MR Image Analysis and Implementation as
FSL. Neuroimage 2004, 23, S208–S219.
45. Pharm. Res. 2010, 62 (2),
90–99.
46.
Materials. 2022,
15 (2), 427.
https://t.me/med1917
316
Metals in Medicine, Volume 2
47.
Engineered Nanomaterials. Biochem. Pharm. 2014, 92 (1), 112–130.
48. J. Control. Release 2009, 133 (1), 2.
49.
Albumin. J. Nanoparticle Res. 2013, 15, 1–5.
50.
Nanoparticles Using Genipa Americana Fruit Extract and its Biological Applications.
Mater. Sci. Eng.: C. 2016, 62, 725–731.
51.
Cell Lines. Nanoscale 2011, 3 (2), 575–580.
52.
Mol. Biol. Evol. 2018, 35 (6), 1547.
53.
Streptomyces griseus Isolate (M8) and Evaluating its Antimicrobial and Anticancer
Activity. Egypt. J. Aquat. Biol. Fisheries 2019, 23 (1), 173–184.
54.
Cladosporium
Antitumor Studies. Int. J. Pharm. 2020, 588, 119729.
55.
Licorice Root Extract: Antimicrobial and Anticancer Study Against HepG2 cell line.
Arab. J. Chem. 2021, 14 (2), 102956.
56.
World J.
Pharm. Res. 2015, 4 (10), 1467–1481.
57.
Antimicrobial and Anticancer Activities. J. Drug Deliv. Sci. Technol. 2020, 57, 101620.
58.
Anacardium Occidentale Leaves Extract. Saudi J. Biol. Sci. 2019, 26 (3), 455–459.
59.
Vibrio alginolyticus) and
its Anticancer and Antioxidant Analysis. J. King Saud Univ.-Sci. 2021, 33 (1), 101260.
60.
Backhousia citriodora
Against MCF-7 Breast and HepG2 Liver Cancer Cell Lines. J. Mater. Sci. 2018, 53 (5),
3106–3118.
61.
Lines. J. Nanoparticle Res. 2013, 15, 1–8.
62.
Acalypha indica
https://t.me/med1917
Principal Applications of Gold Nanoparticles in the Biomedical Field
317
Cancer Cells. Biotechnol Rep. 2014, 4, 42–49.
63. Cajanus cajan husk)
Am. J. Food Sci. Technol. 2015, 3 (1), 1–9.
64.
Cancer
Nanotechnol. 2013, 4, 91–98.
65.
Hibiscus
sabdariffa
Hyperglycemic condition. Biochem. Eng. J. 2016, 105, 264–272.
66.
Soluble Drugs. J. Control. Release 2010, 141 (3), 300–302.
67.
J.
Drug Target. 2018, 26 (7), 525–532.
68.
Cells. J. Mater. Sci.: Mater. Med. 2009, 20, 347–350.
69.
Drugs: Challenges and Opportunities. J. Control. Release 2013, 170 (1), 15–40.
70.
Diabetes 2013, 62 (5), 1697–1708.
71.
J. Clust. Sci. 2021, 1–6.
72.
Diabetes 2013, 62
(5), 1697–1708.
73.
Antibody Conjugates. Small 2009, 5 (9), 1030–1034.
74.
Potential in Melanoma Cells. Colloids Surf. B: Biointerfaces 2020, 194, 111213.
75.
Special Emphasis on Reproductive Organs. Diseases of Aquatic Organisms 1997, 30
(1), 53–72.
76.
Pharmaceutics 2022, 14 (2), 224.
77.
Am. J. Drug Deliv. 2004, 2, 43–57.
https://t.me/med1917
318
Metals in Medicine, Volume 2
78.
Nanoscale 2018, 10 (21), 10166–10172.
79.
N. Engl. J. Med. 2009, 361
(26), 2507–2517.
80.
Nano
Lett. 2018, 18 (4), 2189–2194.
81.
Curr. Med. Chem. 2010, 17 (6),
585–594.
82.
Imaging. Philos. Trans. A Math. Phys. Eng. Sci. 2017, 375 (2107), 20170022.
83.
Bioimaging. Nanosc. Adv. 2021, 3 (10), 2679–2698.
84. Acc.
Chem. Res. 2011, 44 (10), 1050–1060.
85.
86.
optical and Photothermal Properties and Some Applications in Imaging, Sensing,
Biology, and Medicine. Acc. Chem. Res. 2008, 41 (12), 1578–1586.
87.
Exp. Opin. Drug Deliv. 2009, 6 (1 1), 1175–1 194.
88.
Anal. Chem.
2020, 92 (7), 5546–5553.
89.
dielectric particles. J. Chem. Phys. 1981, 75 (3), 1139–1152.
90.
Nanoparticle. Nat. Med. 2012, 18 (5), 829–834.
91. Med.
Princ. Pract. 2008, 17 (2), 89–101.
92.
Oraevsky, A. A. Bioconjugated Gold Nanoparticles As A Molecular Based Contrast
Mol. Imaging Biol. 2004, 6 (5), 341–349.
93.
Small
2016, 12 (20), 2775–2782.
94.
Materials 2022, 15 (9), 3355.
https://t.me/med1917
Principal Applications of Gold Nanoparticles in the Biomedical Field
319
95.
Adv. Healthc. Mater. 2020, 9 (1), 1901229.
96.
Adv. Healthc. Mater. 2019, 8 (24), 1900993.
97.
Bench to the Clinic. Angew. Chem. Int. Ed. Engl. 2019, 58 (13), 4112–4128.
98.
Green Metal Nanoparticles:
Synthesis, Characterization and their Applications
99.
Gold Nanoparticles. Adv. Sci. 2021, 8 (5), 2002788.
100.
Adv. Funct. Mater. 2018, 28 (7), 1705607.
101.
Med. Phys. 2018, 45 (6),
2572–2582.
102.
Wiley Interdiscip. Rev: Nanomed. Nanobiotechnol. 2018, 10 (2),
e1480.
103. Wiley
Interdiscip. Rev: Nanomed. Nanobiotechnol. 2018, 10 (1), e1470.
104.
Nanoscale 2018, 10 (33), 15447–15453.
105.
Anal. Chem.
2013, 85 (20), 9564–9571.
106.
in Advanced Biomedical Applications. Nanosc. Adv. 2020, 2 (9), 3764–3787.
107.
Excitation. RSC Adv. 2015, 5 (4), 2851–2856.
108.
Science 2014, 346 (6215), 1366–1369.
109.
Processes. Appl. Immunocytochem. 2012, 65–96.
110.
Int. J.
Nanomed. 2018, 13, 5637.
https://t.me/med1917
320
Metals in Medicine, Volume 2
111. Sci. Am. 1999,
280 (4), 86–89.
112.
Curr.
Opin. Solid State Mater. Sci. 2017, 21 (2), 92–112.
113.
Biotechnol. Prog. 2017, 33 (3), 590–611.
114.
Regenerative Medicine. Front. Bioeng. Biotechnol. 2019, 7, 113.
115.
J. Tissue Eng. Regen. Med. 2020, 14 (12), 1687–1714.
116.
J. Adv. Res. 2019, 18, 185–201.
117.
Nanomedicine 2012, 7 (9), 1425–1442.
118.
Spherical Nucleic Acids
55–90.
119.
Advances and Perspectives. Chem. Soc. Rev. 2012, 41 (6), 2256–2282.
120.
J. Biomed. Mater. Res. Part A 2011,
99 (3), 493–499.
121.
Engineering and Regenerative Medicine. Nano Lett. 2019, 19 (4), 2198–2206.
122.
Pharmaceutics 2022, 14 (1), 70.
123.
J. Mater. Chem. B. 2020, 8 (32), 7213–7224.
124.
J. Biol.
Eng. 2020, 14, 1–5.
125.
Tissue Eng. Part B: Rev. 2020, 26 (3), 203–216.
126.
J. Clust. Sci. 2020, 31, 99–108.
https://t.me/med1917
Principal Applications of Gold Nanoparticles in the Biomedical Field
321
127.
Sci. Total Environ. 2020, 707, 135976.
128.
Curr.
Opin. Solid State Mater. Sci. 2017, 21 (2), 92–112.
129.
Int. J. Nanomed. 2015, 10, 4383.
130.
Bone Regeneration. Bioact. Mater. 2018, 3 (4), 401–417.
131.
ACS Nano.
2010, 4 (11), 6439–6448.
132.
Chin. Sci. Bull. 2010, 55, 1013–1019.
133.
ACS Appl. Mater. Interfaces
2016, 8 (16), 10049–10069.
134.
Engineering. Turk. J. Biol. 2016, 40 (2), 380–398.
135.
Biomaterials 2015, 65, 175–183.
136.
Physiol. Rep. 2017, 5 (4), e13128.
137.
Enhanced Biocompatibility. J. Mater. Sci.: Mater. Med. 2011, 22, 2803–2812.
138.
Antimicrobial Purposes Against Multi-Drug Resistance Bacteria. Materials 2022, 15
(5), 1799.
139.
to Enhance Antimicrobial Activities. Nano Lett. 2003, 3 (9), 1261–1263.
140.
(III) Ions and Gold Nanoparticles. Biochem. Pharmacol. 2015, 4 (6).
141.
Sci. Rep. 2021, 11 (1), 12546.
142.
Staphylococcus aureus.
Nano Res. 2018, 11, 6237–6243.
https://t.me/med1917
322
Metals in Medicine, Volume 2
143.
Pathogenic Bacteria. Carbohydrate Polymers. 2018, 198, 206–214.
144.
on its Antibacterial Applications and Mechanisms. J. Nanomater. 2021, 2021, 1–8.
145.
on Foodborne Pathogens. Int. J. Nanomed. 2016, 11, 3347.
146.
Curr. Drug Deliv. 2017, 14 (8), 1114–1119.
147.
J. Nanomater.
2020, 2020, 1–3.
148.
Nanoparticles As Smart Antibacterial and Wound Healing Agents. Sci. Rep. 2018, 8 (1),
13674.
149.
Gold Nanoparticles. Int. J. Nanomed. 2015, 10 (sup1), 67–78.
150.
Colloids Surf. B: Biointerfaces. 2017,
158, 397–407.
151.
Nanosheets: Membrane Damage, Metabolic Inactivation, and Oxidative Stress. ACS
Appl. Bio Mater. 2019, 2 (7), 2738–2755.
152.
J. Nanostruct. Chem. 2019, 9,
111–117.
153.
and Gold Nanoparticles are Potent Antimycotics Against Opportunistic Pathogenic
Yeasts and Dermatophytes. Int. J. Nanomed. 2018, 13, 695.
154.
Colloids Surf. B: Biointerfaces. 2013, 101,
162–170.
155.
Patients. Al-Azhar J. Pharm. Sci. 2019, 60 (2), 26–42.
156.
Candida albicans. Mater.
Res. Bull. 2019, 119, 110563.
157.
Gold Bulletin 2021, 54, 31–36.
https://t.me/med1917
Principal Applications of Gold Nanoparticles in the Biomedical Field
323
158.
Nanomaterials 2022, 12 (5), 814.
159.
Biomed. Pharmacother. 2019, 109, 2561–2572.
160.
J. Nanobiotechnol. 2021, 19, 1–5.
161. Anti-inflammatory Activity of Gold and
Graphene Oxide Nanoparticles In-Vitro Study
162.
Oxides. Sci. Rep. 2021, 11 (1), 23129.
163.
Commiphora wightii. Mater Technol, In Press,
2021.
164.
Induction. ACS Appl. Mater. Interfaces 2019, 11 (36), 32706–32719.
165.
Molecules 2022, 27 (5), 1551.
166.
promises and challenges. Nanotechnol. Rev. 2014, 3 (3), 269–280.
167. Ann. Rev. Med.
2019, 70, 273–288.
168.
Move. EMBO Mol. Med. 2013, 5 (11), 1642–1661.
169. Nature 1992, 357, 455–460.
170.
RSC Adv. 2019, 9 (41), 23894–23907.
171.
Delivery. Appl. Microbiol. Biotechnol 2003, 62, 27–34.
172.
Nanotechnology. Chem. Rev. 2004, 104 (1), 293–346.
173. Expert
Rev. Mol. Diagn. 2009, 9 (5), 511–524.
174.
Nano Lett. 2005, 5 (1), 21–25.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана